PETER HIATT to Cross-Over Studies
This is a "connection" page, showing publications PETER HIATT has written about Cross-Over Studies.
Connection Strength
0.028
-
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros. 2014 Dec; 13(6):674-80.
Score: 0.028
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.